These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33979342)

  • 1. Opioid Treatment Deserts: Concept development and application in a US Midwestern urban county.
    Hyder A; Lee J; Dundon A; Southerland LT; All D; Hammond G; Miller HJ
    PLoS One; 2021; 16(5):e0250324. PubMed ID: 33979342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accessibility of Opioid Treatment Programs Based on Conventional vs Perceived Travel Time Measures.
    Kim J; Lee J; Thornhill TA; Dennett J; Lu H; Howell B; Grau LE; Fiellin DA; Heimer R; Gonsalves G
    JAMA Netw Open; 2024 Feb; 7(2):e240209. PubMed ID: 38376839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior.
    Mitchell P; Samsel S; Curtin KM; Price A; Turner D; Tramp R; Hudnall M; Parton J; Lewis D
    Soc Sci Med; 2022 Jun; 302():114992. PubMed ID: 35512612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.
    Grover JM; Alabdrabalnabi T; Patel MD; Bachman MW; Platts-Mills TF; Cabanas JG; Williams JG
    Prehosp Emerg Care; 2018; 22(3):281-289. PubMed ID: 29297739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: Enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky.
    Shrestha S; Lindstrom MR; Harris D; Rock P; Srinivasan S; Pustz JC; Bayly R; Stopka TJ
    J Subst Use Addict Treat; 2023 Jul; 150():209077. PubMed ID: 37211155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of opioid use disorder in Kentucky's counties: A two-year multi-sample capture-recapture analysis.
    Thompson K; Barocas JA; Delcher C; Bae J; Hammerslag L; Wang J; Chandler R; Villani J; Walsh S; Talbert J
    Drug Alcohol Depend; 2023 Jan; 242():109710. PubMed ID: 36469995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race, ethnicity, and emergency department post-overdose care.
    Reddy NG; Jacka B; Ziobrowski HN; Wilson T; Lawrence A; Beaudoin FL; Samuels EA
    J Subst Abuse Treat; 2021 Dec; 131():108588. PubMed ID: 34384652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
    Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
    J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between buprenorphine provider availability and opioid deaths among US counties.
    Jones CW; Christman Z; Smith CM; Safferman MR; Salzman M; Baston K; Haroz R
    J Subst Abuse Treat; 2018 Oct; 93():19-25. PubMed ID: 30126537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying high-risk areas for nonfatal opioid overdose: a spatial case-control study using EMS run data.
    Pesarsick J; Gwilliam M; Adeniran O; Rudisill T; Smith G; Hendricks B
    Ann Epidemiol; 2019 Aug; 36():20-25. PubMed ID: 31405719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities for Emergency Medical Services Intervention to Prevent Opioid Overdose Mortality.
    Barefoot EH; Cyr JM; Brice JH; Bachman MW; Williams JG; Cabanas JG; Herbert KM
    Prehosp Emerg Care; 2021; 25(2):182-190. PubMed ID: 32176548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best Practices for a Novel EMS-Based Naloxone Leave behind Program.
    Scharf BM; Sabat DJ; Brothers JM; Margolis AM; Levy MJ
    Prehosp Emerg Care; 2021; 25(3):418-426. PubMed ID: 32420791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal Trends in Opioid Overdose Deaths by Race for Counties in Ohio.
    Kline D; Pan Y; Hepler SA
    Epidemiology; 2021 Mar; 32(2):295-302. PubMed ID: 33394810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMS naloxone administration as non-fatal opioid overdose surveillance: 6-year outcomes in Marion County, Indiana.
    Ray BR; Lowder EM; Kivisto AJ; Phalen P; Gil H
    Addiction; 2018 Dec; 113(12):2271-2279. PubMed ID: 30255531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone Administration Frequency During Emergency Medical Service Events - United States, 2012-2016.
    Cash RE; Kinsman J; Crowe RP; Rivard MK; Faul M; Panchal AR
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(31):850-853. PubMed ID: 30091966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population.
    Ferries E; Racsa P; Bizzell B; Rhodes C; Suehs B
    J Manag Care Spec Pharm; 2021 May; 27(5):596-606. PubMed ID: 33908274
    [No Abstract]   [Full Text] [Related]  

  • 18. Medication Treatment of Opioid Use Disorder.
    Bell J; Strang J
    Biol Psychiatry; 2020 Jan; 87(1):82-88. PubMed ID: 31420089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic access to buprenorphine prescribers for patients who use public transit.
    Drake C; Donohue JM; Nagy D; Mair C; Kraemer KL; Wallace DJ
    J Subst Abuse Treat; 2020 Oct; 117():108093. PubMed ID: 32811632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criminal justice continuum for opioid users at risk of overdose.
    Brinkley-Rubinstein L; Zaller N; Martino S; Cloud DH; McCauley E; Heise A; Seal D
    Addict Behav; 2018 Nov; 86():104-110. PubMed ID: 29544869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.